Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online July 19, 2007
Stem Cells Vol. 25 No. 10 October 2007, pp. 2488 -2497
doi:10.1634/stemcells.2007-0102; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0102v1
25/10/2488    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoyama, K.
Right arrow Articles by Bernstein, I. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoyama, K.
Right arrow Articles by Bernstein, I. D.

TISSUE-SPECIFIC STEM CELLS

The Interaction of the Wnt and Notch Pathways Modulates Natural Killer Versus T Cell Differentiation

Keisuke Aoyamaa, Colleen Delaneya,b, Barbara Varnum-Finneya, Aimee D. Kohnc,d, Randall T. Moonc, Irwin D. Bernsteina,b

aClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA;
bDepartment of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA;
cHoward Hughes Medical Institute, Department of Pharmacology, and Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine, Seattle, Washington, USA;
dDivision of Hematology, University of Washington School of Medicine, Seattle, Washington, USA

Key Words. Umbilical cord blood • Wnt • Notch • Natural killer cells • T cells

Correspondence: Irwin D. Bernstein, M.D., Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., D2-373, Seattle, Washington 98109, USA. Telephone: 206-667-4886; Fax: 206-667-6084; e-mail: ibernste{at}fhcrc.org

Received February 13, 2007; accepted for publication July 9, 2007.
First published online in STEM CELLS EXPRESS   July 19, 2007.



The Wnt and Notch signaling pathways have been independently shown to play a critical role in regulating hematopoietic cell fate decisions. We previously reported that induction of Notch signaling in human CD34+CD38 cord blood cells by culture with the Notch ligand Delta1 resulted in more cells with T or natural killer (NK) lymphoid precursor phenotype. Here, we show that addition of Wnt3a to Delta1 further increased the percentage of CD34CD7+ and CD34CD7+cyCD3+ cells with increased expression of CD3{varepsilon} and preT{alpha}. In contrast, culture with Wnt3a alone did not increase generation of CD34CD7+ precursors or expression of CD3{varepsilon} or preT{alpha} gene. Furthermore, Wnt3a increased the amount of activated Notch1, suggesting that Wnt modulates Notch signaling by affecting Notch protein levels. In contrast, addition of a Wnt signaling inhibitor to Delta1 increased the percentage of CD56+ NK cells. Overall, these results demonstrate that regulation of Notch signaling by the Wnt pathway plays a critical role in differentiation of precursors along the early T or NK differentiation pathways.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
DevelopmentHome page
C. S. Jayasena, T. Ohyama, N. Segil, and A. K. Groves
Notch signaling augments the canonical Wnt pathway to specify the size of the otic placode
Development, July 1, 2008; 135(13): 2251 - 2261.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.